| 517.37 | V08AB10 | iomeprol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K | ||
| 517.38 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 278,85 | K | ||
| 517.39 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K | ||
| 517.40 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 307,80 | K | ||
| 517.41 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 236,75 | K | ||
| 517.42 | V08AB09 | iodixanol (koncentrace 150mgI/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 232,- | K/P | ||
| 84340 84339 | VISIPAQUE 150MG I/ML VISIPAQUE 150MG I/ML | inj 6×200ml inj 10×50ml | NYI NYI | N N | |||||
| 517.43 | V08AB09 | iodixanol (koncentrace 270mgI/ml, do 30 ml včetně v jedné ampuli ) | parent. | 10 | ML | 362,45 | K/P | ||
| 84341 | VISIPAQUE 270MG I/ML | inj 10×20ml | NYI | N | |||||
| 517.44 | V08AB09 | iodixanol (koncentrace 270mgI/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 303,80 | K/P | ||
| 84342 84343 84344 | VISIPAQUE 270MG I/ML VISIPAQUE 270MG I/ML VISIPAQUE 270MG I/ML | inj 10×50ml inj 10×100ml inj 6×200ml | NYI NYI NYI | N N N | |||||
| 517.45 | V08AB09 | iodixanol (koncentrace 320mgI/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 384,90 | K/P | ||
| 84345 | VISIPAQUE 320MG I/ML | inj 10×20ml | NYI | N | |||||
| 517.46 | V08AB09 | iodixanol (koncentrace 320mgI/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 309,30 | K/P | ||
| 84346 84347 84348 | VISIPAQUE 320MG I/ML VISIPAQUE 320MG I/ML VISIPAQUE 320MG I/ML | inj 10×50ml inj 10×100ml inj 6×200ml | NYI NYI NYI | N N N | |||||
| 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K | |||||
|---|---|---|---|---|---|---|---|---|---|
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg I/ml) | parent. | 10 | ML | 75,95 | K | ||
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg I/ml) | parent. | 10 | ML | 38,25 | K | ||
| 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 40,25 | K | ||
| 03394 | ENDOBIL PRO INF. I. V. | inf 100ml | BCC | I | |||||
| 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | |||||
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 307,60 | K | ||
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 473,15 | K | ||
| 03552 | LIPIODOL ULTRA-FLUID | inj 5×5ml | BGL | D | |||||
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | |||||
| 520.1 | V08BA | síran barnatý | p.o. | 100 | GM | 34,05 | K | ||
| 06303 94370 | MICROPAQUE PRONTOBARIO 60% | sus 1×2000ml sus 1×5lt | GUE BCC | D I | |||||
| 520.2 | V08BA | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 157,65 | K | |||
| 44367 | MICROPAQUE CT | sus 1×2000ml/ 100gm | GUE | D | ||||||
| 520.3 | V08BA | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 46,80 | K | |||
| 91066 | MICROPAQUE COLON | plv 1×800gm | GUE | D | ||||||
| 520.4 | V08BA | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 96,75 | K | |||
| 62535 | PRONTOBARIO ESOFAGO | sus 6×250ml (tuba) | BCC | I | ||||||
| 520.5 | V08BA | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,95 | K | |||
| 56578 | PRONTOBARIO HD | plv 24×340gm | BCC | I | ||||||
| 521 | V08CA | paramagnetické kontrastní látky | parent. | K | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | |||
| 75660 75659 | MAGNEVIST MAGNEVIST | inj 1×10ml inj 1×5ml | SAG SAG | D D | ||||||
| 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | |||
| 96352 | MAGNEVIST | inj 1×20ml | SAG | D | ||||||
| 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | |||
| 55822 78815 | OMNISCAN 0.5MMOL/ML OMNISCAN 0.5MMOL/ML | inj 10×5ml inj 10×10ml | NYI NYI | N N | ||||||
| 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | |||
| 78816 78817 | OMNISCAN 0.5MMOL/ML OMNISCAN 0.5MMOL/ML | inj 10×15ml inj 10×20ml | NYI NYI | N N | ||||||
| 521.5 | V08DA | mikrokrystalická suspense galaktozy a kys. palmitové | parent. | 1 | GM | 1169,20 | H | |||